Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.87−0.54 (-7.29%)
Close on Nov 18, 2026Market cap $622.17MP/E –Yield –
Verastem operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Verastem's operating cash flow for the twelve months ending Jun 30, 2026 was -$162.20M. For fiscal 2025 it was -$137.51M. The highest annual figure on record is -$9.37M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$137.51M | – |
| FY2024 | Dec 31, 2024 | -$104.77M | – |
| FY2023 | Dec 31, 2023 | -$86.46M | – |
| FY2022 | Dec 31, 2022 | -$63.67M | – |
| FY2021 | Dec 31, 2021 | -$53.50M | – |
| FY2020 | Dec 31, 2020 | -$33.51M | – |
| FY2019 | Dec 31, 2019 | -$138.52M | – |
| FY2018 | Dec 31, 2018 | -$74.52M | – |
| FY2017 | Dec 31, 2017 | -$57.31M | – |
| FY2016 | Dec 31, 2016 | -$29.48M | – |
| FY2015 | Dec 31, 2015 | -$45.56M | – |
| FY2014 | Dec 31, 2014 | -$36.90M | – |
| FY2013 | Dec 31, 2013 | -$26.31M | – |
| FY2012 | Dec 31, 2012 | -$22.60M | – |
| FY2011 | Dec 31, 2011 | -$9.37M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$43.91M | – |
| Q1 FY2026 | Mar 31, 2026 | -$52.12M | – |
| Q4 FY2025 | Dec 31, 2025 | -$29.95M | – |
| Q3 FY2025 | Sep 30, 2025 | -$36.22M | – |
| Q2 FY2025 | Jun 30, 2025 | -$32.66M | – |
| Q1 FY2025 | Mar 31, 2025 | -$38.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$25.10M | – |
| Q1 FY2024 | Jun 30, 2024 | -$55.88M | – |
| Q4 FY2023 | Dec 31, 2023 | -$29.68M | – |
| Q3 FY2023 | Sep 30, 2023 | -$16.59M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.90M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.29M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.62M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.08M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.69M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.28M | – |
| Q4 FY2021 | Dec 31, 2021 | -$9.93M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.83M | -124.2% |
| Q2 FY2021 | Jun 30, 2021 | -$13.42M | – |
| Q1 FY2021 | Mar 31, 2021 | -$19.32M | – |
| Q4 FY2020 | Dec 31, 2020 | -$21.70M | – |
| Q3 FY2020 | Sep 30, 2020 | $44.75M | – |
| Q2 FY2020 | Jun 30, 2020 | -$22.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$34.00M | – |
| Q4 FY2019 | Dec 31, 2019 | -$37.22M | – |
| Q3 FY2019 | Sep 30, 2019 | -$27.85M | – |
| Q2 FY2019 | Jun 30, 2019 | -$34.67M | – |
| Q1 FY2019 | Mar 31, 2019 | -$38.78M | – |
| Q4 FY2018 | Dec 31, 2018 | -$19.19M | – |
| Q3 FY2018 | Sep 30, 2018 | -$22.56M | – |
| Q2 FY2018 | Jun 30, 2018 | -$10.31M | – |
| Q1 FY2018 | Mar 31, 2018 | -$22.45M | – |
| Q4 FY2017 | Dec 31, 2017 | -$20.33M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.85M | – |
| Q2 FY2017 | Jun 30, 2017 | -$14.48M | – |
| Q1 FY2017 | Mar 31, 2017 | -$10.65M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.95M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.02M | – |
| Q2 FY2016 | Jun 30, 2016 | -$6.69M | – |
See a number that looks wrong?